Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of CKD-390 Tablet for chronic hepatitis B, with current status not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• CKD-390 Tablet

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Chronic Hepatitis B | Phase 3 | Status: UNKNOWN